Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

1(25%)

Results Posted

0%(0 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_2

75%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

3(75.0%)

Phase 3Large-scale testing

1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Terminated(1)

Detailed Status

Completed2

Active, not recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 3

Trials by Phase

Phase 23 (75.0%)

Phase 31 (25.0%)

Trials by Status

active_not_recruiting125%

terminated125%

completed250%

Recent Activity

1 active trials

Showing 4 of 4

active_not_recruitingphase_2

Topical 10% Povidone-Iodine in Preventing White Spots

NCT06616207

completedphase_2

Trial of Antiseptic Irrigation for Pleural Infection

NCT05546762

completedphase_2

Povidone-iodine Versus Normal Saline Solution in Vaginal Cleansing in Laparoscopy

NCT02591251

terminatedphase_3

A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections

NCT00528008

Clinical Trials (4)

Showing 4 of 4 trials

NCT06616207Phase 2

Topical 10% Povidone-Iodine in Preventing White Spots

Active Not Recruiting

NCT05546762Phase 2

Trial of Antiseptic Irrigation for Pleural Infection

Completed

NCT02591251Phase 2

Povidone-iodine Versus Normal Saline Solution in Vaginal Cleansing in Laparoscopy

Completed

NCT00528008Phase 3

A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections

Terminated

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4